Twelve-Month-Old Behind on Vaccines, a Sibling's Febrile Seizure, and Travel to a Measles Outbreak

Give both live vaccines today, as two separate injections. MMR and varicella are both live attenuated; when two live injectables are not given on the same day they must be separated by at least 28 days, so "same day, different sites" is the efficient and safe choice. MMRV is not an option here - it is not licensed for children under 4 years precisely because of febrile seizure risk.

Refuse the split-MMR request, with reasons:

• Monovalent measles, mumps, and rubella vaccines are not generally available in the United States, and splitting has no demonstrated safety benefit.
• It converts one injection into three visits and delays complete protection by months - during a measles outbreak and 10 weeks before departure, that delay is the real risk.
• The child is already 4 months behind; adding artificial spacing compounds it.

Catch-up doses due: DTaP #3, IPV #3, Hib #3, PCV #4 (she is ≥12 months and ≥8 weeks from dose 3), hepatitis A #1, plus MMR #1 and varicella #1. Seven injections at one visit is acceptable, but prioritize MMR and varicella today because they are the outbreak- and travel-critical ones, and schedule the inactivated catch-up at a visit 4 weeks later if the family or staff prefer fewer sticks. Either sequence is defensible; delaying the live vaccines is not.

Travel timing: protective efficacy begins about 14 days after MMR, so 10 weeks is comfortable. Confirm the second MMR will be due at 4–6 years and varicella #2 three months after #1. Document a written catch-up schedule with dates - verbal plans get lost during an international move.

The febrile seizure question:

• A family history of febrile seizure is not a contraindication or even a precaution to MMR. A personal history of seizure is a precaution for MMRV only - not for MMR given separately - and MMRV isn't used at this age anyway.
• Give the honest numbers: fever-related seizure after MMR occurs on the order of 1 in 3,000 doses, typically 7–10 days post-vaccination; the sibling's event is a known, self-limited phenomenon and does not mean Nora will have one.
• Fever from measles itself is far higher and carries a genuine risk of pneumonia and encephalitis.
• Practical advice: no prophylactic antipyretics scheduled around the dose (they may blunt the immune response); treat fever if it occurs with weight-based acetaminophen or ibuprofen; teach what a febrile seizure looks like and what to do.

The immunocompromised household contact:

• A household member on chemotherapy is not a contraindication to vaccinating the child. Wild-type measles or varicella introduced by an unvaccinated toddler is a far greater threat to a neutropenic adult than vaccine-strain virus.
• MMR is not transmitted person-to-person. Varicella vaccine strain can, rarely, cause a rash and be transmitted - so if a vesicular rash develops in the 4–6 weeks after vaccination, cover the lesions and avoid direct contact until crusted.
• Flag this for the grandmother's oncology team so they can plan; also verify the grandmother's own varicella immunity.

The day care: four unvaccinated contacts raise the probability of exposure. This strengthens, not weakens, the case for same-day vaccination.

Framing: this is a partial acceptance, not a refusal - treat it as progress. Dismissal from the practice is inappropriate and, in most jurisdictions, vaccine refusal alone is not a reportable form of neglect. Coercion damages the relationship and the long-term vaccine trajectory.

Clinical steps:

1. Give what is accepted, and say so aloud: "We're getting the two most urgent ones done today - that's a real win."
2. Ask a focused, non-judgmental question about the specific concern (fear of too many shots? a reaction they read about? distrust of one manufacturer?). Use motivational interviewing - elicit their reasons, reflect them, then offer information rather than a lecture.
3. Offer a concrete near-term plan: a nurse-only visit in 2–4 weeks for DTaP/IPV/Hib/PCV/HepA, with a scheduled date before they leave the country. Specific dates convert intention into action.
4. Explain the specific risk of deferring: pertussis in an infant who will be traveling, and polio in a destination country. Keep it proportional - no scare tactics.

Documentation that protects the child and you:

• The vaccines offered, the ones given, the ones declined, and the specific reason stated by the parent.
• The risks of deferral that were discussed, in plain language.
• The written catch-up schedule provided and the follow-up appointment date.
• A signed declination form for the refused vaccines if your practice uses one, plus a copy to the family.
• That no coercion was applied and the door was left open.

Close the loop: flag the chart for outreach before the departure date, notify the receiving provider if one is identified, and confirm the child's record is portable. Re-offer at every single contact - acceptance often happens on the third or fourth conversation.